Editorial: Analgesia in myocardial infarction.
D000698:Analgesia; D000700:Analgesics / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D003501:Cyclizine / Q000627:therapeutic use; D006323:Heart Arrest / Q000188:drug therapy; D003932:Heroin / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D008691:Methadone / Q000009:adverse effects; D009020:Morphine / Q000009:adverse effects; D009203:Myocardial Infarction / Q000188:drug therapy*; D009325:Nausea / Q000139:chemically induced; D010146:Pain / Q000188:drug therapy; D010423:Pentazocine / Q000009:adverse effects; D011652:Pulmonary Circulation / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D012770:Shock, Cardiogenic / Q000150:complications; D013147:Spirometry; D014839:Vomiting / Q000139:chemically induced
D000700:Analgesics; D003932:Heroin; D009020:Morphine; D003501:Cyclizine; D010423:Pentazocine; D008691:Methadone